This patent covers specific peptides derived from erythropoietin, as well as from other molecules, that have ability to increase neurite outgrowth in cell culture. Specifically, the claims appear to be restricted only to a method of increasing neurite outgrowth in cell culture.
The neuroprotective roles of erythropoietin have been known for many years and have been assessed and are being assessed clinically today for conditions ranging from stroke to ALS.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.